Support Bristol's Highly Qualified Independent Nominees for Adv... ( THE CURRENT BOARD'S INTERESTS ARE NOT...)

Support Bristol's Highly Qualified Independent Nominees for Advocat Board

Date:5/19/2009

THE CURRENT BOARD'S INTERESTS ARE NOT ALIGNED WITH STOCKHOLDERS

ADVOCAT BOARD NEEDS TO EXPLORE THE SALE OR MERGER OF THE COMPANY

HOLLYWOOD, Calif., May 19 /PRNewswire/ -- Bristol Investment Fund, Ltd. ("Bristol") announced today that it has sent a letter to the stockholders of Advocat, Inc. (the "Company") (Nasdaq: AVCA) urging stockholders to elect its two highly qualified and independent director nominees, Paul Kessler and Richard McKilligan, at the Company's 2009 annual meeting of stockholders on May 29, 2009. Bristol, together with the nominees, beneficially owns an aggregate of 422,540 shares of common stock of the Company, representing approximately 7.44% of the outstanding shares of the Company's common stock.

The full text of the letter follows:

May 19, 2009

Dear Fellow Stockholders of Advocat Inc.:

Bristol Investment Fund, Ltd. ("Bristol") is seeking your support to elect two highly qualified nominees to the Board of Directors of Advocat Inc. at the 2009 Annual meeting of stockholders to be held at 9:00 a.m. (Central Daylight Time), May 29, 2009, at the Company's offices, 1621 Galleria Boulevard, Brentwood, Tennessee 37027. We have become increasingly concerned over the direction, compensation and corporate governance at Advocat during the past three years we have been stockholders. Bristol, as one of Advocat's largest stockholders, beneficially owning an aggregate 422,540 Shares as of the date hereof, approximately 7.44% of the Shares outstanding, believes recent actions by the Board of Directors have not been in the best interests of stockholders and have only served to further entrench management and the Board.

Please vote the GOLD proxy to support our slate of highly qualified independent director nominees so we can try
'/>"/>

0

GOOD

Page: 1 2 3 4 5 6 7 8 9
Related medicine news :

1. ASPH Supports President Obamas Selection of New York City Health Commissioner Thomas R. Frieden, MD, MPH, for CDC Director
2. Major Physician Group Issues Statement in Support of Physician/Industry Relationships
3. Trust for Americas Health Supports Appointment of Thomas Frieden to Lead CDC
4. Kinovate Life Sciences, Inc. and Nitto Denko Corporation Announce Successful Development of NittoPhase™ HL High Loading Solid Support for Oligonucleotide Synthesis
5. arc Thrift Stores to Honor Individuals and Businesses Who Support People With Developmental Disabilities
6. Coalition for Quality & Patient Safety of Chicagoland PSO Taps ECRI Institute PSO for Patient Safety Support
7. Connectyx CEO Announces Support of the Obama Plan to Invest in Health Information Technology
8. Bonnie Hunt, Melina Kanakaredes and Dr. Ruth Westheimer Lend Their Support to Childrens Brain Tumor Foundation Benefit
9. AAHSA Joins Sixty Aging and Disability Groups to Fight for Long-Term Services and Supports in Health Care Reform
10. Association for the Treatment of Tobacco Use and Dependence Supports the FDA Ban of Electronic Cigarettes
11. Quigley Corporation Receives Support from Leading Independent Proxy Advisory Firms; RiskMetrics and Glass Lewis Reject Dissident Stockholder Ted Karkus, Citing Failure to Provide Detailed Business Plan

Post Your Comments:

Support Bristol's Highly Qualified Independent Nominees for Adv...( THE CURRENT BOARD'S INTERESTS ARE NOT...),Health